Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Novel idea to treat ATTR amyloidosis enters clinical trial
Novel idea to treat ATTR amyloidosis enters clinical trial
Can this scavenger receptor help solve high cholesterol?
Can this scavenger receptor help solve high cholesterol?
Fibrosis: confronting a global challenge
New strategy to target disease affecting 2.5 billion people
Tapping the power and mystery of embryonic macrophages
How can they help us regenerating or remodel an injured heart
Career taking flight: A trainee’s perspective
Staying motivated toward a career in clinical science
Canada’s largest meeting on heart failure
Partnership sparks world-class event
This special platform models cardiac fibrosis
Using a 3-D tissue model to study leading cause of HF
Mapping molecular signals that go awry in heart failure
New Ted Rogers study targets dilated cardiomyopathy
Heart Failure Update 2017
Canada’s largest meeting on heart failure is coming this May
Beyond antibiotics: novel ways to treat endocarditis
How to prevent bacteria from colonizing heart valves